Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-19

Clinical Trial Update: Study on Immunization Schedule of Beijing Tiantan Biological's Measles-mumps-rubella(MMR) Vaccine [Phase 4]

View source ↗

Summary

A Phase 4 trial sponsored by the Centers for Disease Control and Prevention, China, evaluated the immunization schedule for Beijing Tiantan Biological's measles…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Measles, Mumps, Rubella vaccine (Measles, Mumps, Rubella vaccine)

Snippet

Sponsor: Centers for Disease Control and Prevention, China | Conditions: Measles, Mumps | Phase 4 | Status: COMPLETED